Page last updated: 2024-10-29

iodixanol and Anemia, Sickle Cell

iodixanol has been researched along with Anemia, Sickle Cell in 2 studies

iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.

Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jensen, J1
Lin, T1
Fishman, EK1
Johnson, PT1
Losco, P1
Nash, G1
Stone, P1
Ventre, J1

Other Studies

2 other studies available for iodixanol and Anemia, Sickle Cell

ArticleYear
Pulmonary CTA in sickle cell patients: quantitative assessment of enhancement quality.
    Emergency radiology, 2017, Volume: 24, Issue:6

    Topics: Adult; Anemia, Sickle Cell; Case-Control Studies; Computed Tomography Angiography; Contrast Media; F

2017
Comparison of the effects of radiographic contrast media on dehydration and filterability of red blood cells from donors homozygous for hemoglobin A or hemoglobin S.
    American journal of hematology, 2001, Volume: 68, Issue:3

    Topics: Anemia, Sickle Cell; Blood Donors; Contrast Media; Dose-Response Relationship, Drug; Erythrocyte Ind

2001